Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Fragapane

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Clinical Immunology|May 22, 2007
Response of influenza vaccines against heterovariant influenza virus strains in adults with chronic diseasesV Baldo, T Baldovin, A Floreani, et al.
European Journal of Epidemiology|October 16, 2001
Increased immunogenicity of the MF59-adjuvanted influenza vaccine compared to a conventional subunit vaccine in elderly subjectsR Gasparini, T Pozzi, E Montomoli, et al.
Epidemiology and Infection|November 18, 1997
Immunity to diphtheria in SienaR Gasparini, T Pozzi, E Fragapane, et al.
Clinical and Vaccine Immunology : CVI|November 16, 2007
Safety and immunogenicity of two influenza virus subunit vaccines, with or without MF59 adjuvant, administered to human immunodeficiency virus type 1-seropositive and -seronegative adultsP Durando, D Fenoglio, A Boschini, et al.
Journal of Preventive Medicine and Hygiene|February 1, 2013
A phase II, randomised clinical trial to demonstrate the non-inferiority of low-dose MF59-adjuvanted pre-pandemic A/H5N1 influenza vaccine in adult and elderly subjectsH Czajka, S Unal, S Ulusoy, et al.
Vaccine|February 13, 1999
Prevalence of diphtheria toxin antibodies in human sera from a cross-section of the Italian populationM Bergamini, N Comodo, R Gasparini, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Clinical Immunology|May 22, 2007
Response of influenza vaccines against heterovariant influenza virus strains in adults with chronic diseasesV Baldo, T Baldovin, A Floreani, et al.
European Journal of Epidemiology|October 16, 2001
Increased immunogenicity of the MF59-adjuvanted influenza vaccine compared to a conventional subunit vaccine in elderly subjectsR Gasparini, T Pozzi, E Montomoli, et al.
Epidemiology and Infection|November 18, 1997
Immunity to diphtheria in SienaR Gasparini, T Pozzi, E Fragapane, et al.
Clinical and Vaccine Immunology : CVI|November 16, 2007
Safety and immunogenicity of two influenza virus subunit vaccines, with or without MF59 adjuvant, administered to human immunodeficiency virus type 1-seropositive and -seronegative adultsP Durando, D Fenoglio, A Boschini, et al.
Journal of Preventive Medicine and Hygiene|February 1, 2013
A phase II, randomised clinical trial to demonstrate the non-inferiority of low-dose MF59-adjuvanted pre-pandemic A/H5N1 influenza vaccine in adult and elderly subjectsH Czajka, S Unal, S Ulusoy, et al.
Vaccine|February 13, 1999
Prevalence of diphtheria toxin antibodies in human sera from a cross-section of the Italian populationM Bergamini, N Comodo, R Gasparini, et al.
Pageof 1